Occam Places David Lynch as CBO at Strateos
Strateos, a DCVC/Lux Capital investment, is a pioneer in the development of remote access laboratories and lab automation software for life sciences discovery.
In 2021, Occam recruited David Lynch as the company’s CBO. Previously, David served as the VP of Business Development at Premier Research. Prior to his stint at Premier Research, David held various Business Development roles at biotechnology vendors & equipment manufacturers, such as PerkinElmer and Affymetrix.
Occam Global is an executive recruiting and leadership advisory firm with specialties across technological fields including Biotech, TechBio, AI-ML, Cell/Gene Therapy, Diagnostics/Genomics, Medical Devices, Research Tools, Digital Health, Alternative Energy, AgTech, EdTech, Robotics as well as adjacencies within Venture Capital and Private Equity. Occam helps build leadership teams that meet the demands of the rapidly developing, competitive, and challenging industries it serves. Occam Global recruits leading C-Suite executives and board members for the most exciting and innovative clients across the world with a specific focus on the UK, Continental Europe, the US, and Asia.